Vaccins contre Covid-19 (SARS -CoV- 2) entre réalité et mensonge, situation actuelle en Algérie ( El Oued comme exemple)
No Thumbnail Available
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Université of Eloued
Abstract
The COVID-19 vaccine and since its appearance and availability, it has raised a large wave
of controversy, thus, the world population has begun to question its safety, its nature and its
effectiveness following which a large number individuals have decided not to want to be
vaccinated. In addition, a large number of studies have been launched with the aim of restoring
public confidence in the anti-SARS-CoV-2 vaccine. These studies have concerned, in particular,
the effectiveness of these vaccines, the main causes of hesitation to get vaccinated in order to find
possible remedies. Our study is part of this framework, so we carried out a survey study based on
two types of questionnaire: the first was to study attitudes and behaviors of vaccination against
Covid-19 (directed at vaccinated individuals) and the second aimed to study the main reasons for
hesitancy towards vaccination against COVID-19. Thus the analyzes of the data collected were
able to show that: 41.23% of vaccinated individuals had a history of COVID-19, which played a
positive role in encouraging people to be vaccinated. Although there is a high rate of individuals
who have already been immunized against COVID-19 (41.23%) while almost 1/3 (28.86%) of
vaccinated individuals have been reinfected again. Adverse effects of vaccines that have been
reported are: fever (51.54% of cases), pain and swelling at the injection site (21.64%), rash (2.06%)
and onset pimples accompanied by body itching sensations (1.03%). In addition, the vaccine brands
that are in use in Algeria are: AstraZeneca, Sinopharm, Sputnik-V, Sinovac and Jonssen, while the
brand most used in the wilaya of EL Oued during the study period was Sinovac. On the other hand,
the hesitation of vaccination is mainly due to the two main reasons: the mistrust of the public
towards these vaccines 73.4% and the phobia against the injections and in particular if it is about
the vaccine (14.89% ).
Description
Toxicologie Fondamantale
Keywords
SARS-CoV-2, vaccines against COVID-19, efficacy, vaccine hesitancy., SARS-CoV-2 ، لقاحات ضد COVID-19 ، نجاعة ، تردد اللقاح.